Antibacterial bioactive glass S53P4 for chronic bone infections : a multinational study

N. Lindfors, J. Geurts, L. Drago, J.J. Arts, V. Juutilainen, P. Hyvönen, A.J. Suda, A. Domenico, S. Artiaco, C. Alizadeh, A. Brychcy, J. Bialecki, C.L. Romanò

Onderzoeksoutput: Hoofdstuk in Boek/Rapport/CongresprocedureHoofdstukAcademicpeer review

16 Citaties (Scopus)

Uittreksel

Osteomyelitis is an infectious process in bone that occasionally leads to bone destruction. Traditionally the surgical treatment procedure is performed in combination with systemic and local antibiotics as a two-stage procedure that uses autograft or allograft bone for filling of the cavitary defect. Bioactive glass (BAG-S53P4) is a bone substitute with proven antibacterial and bone bonding properties. One hundred and sixteen patients who had verified chronic osteomyelitis was treated using BAG-S53P4 as part of the treatment. Most of the patients had previously undergone numerous procedures sometimes for decades. A register of patient data obtained from 11 centers from Finland Italy the Netherlands Germany Azerbaijan and Poland was set-up and continuously maintained at Helsinki University Central Hospital. The location of the osteomyelitis was mainly in the tibia followed by the femur and then the calcaneus. The median age of the patients was 48 years (15–87). The patients were either treated according to a one-stage procedure without local antibiotics (85 %) or by a two-stage procedure using antibiotic beads in the first procedure (15 %). The minimum follow-up was 1 year (12–95 months median 31). The cure rate was 104/116 the total success rate 90 % and most of the patients showed a rapid recovery. The study shows that (BAG-S53P4) can be used in a one-stage procedure in treatment of osteomyelitis with excellent results.

TaalEngels
TitelA Modern Approach to Biofilm-Related Orthopaedic Implant Infections
RedacteurenL. Drago
Plaats van productieDordrecht
UitgeverijSpringer
Pagina's81-92
Aantal pagina's12
ISBN van elektronische versie978-3-319-52274-6
ISBN van geprinte versie978-3-319-52273-9
DOI's
StatusGepubliceerd - 2017

Publicatie series

NaamAdvances in Experimental Medicine and Biology
Volume971
ISSN van geprinte versie0065-2598
ISSN van elektronische versie2214-8019

Vingerafdruk

Bone
Bone and Bones
Osteomyelitis
Anti-Bacterial Agents
Infection
Bone Substitutes
Bioactive glass
Autografts
Allografts
Azerbaijan
Calcaneus
Recovery
Defects
Poland
Finland
bioactive glass S53P4
Tibia
Netherlands
Femur
Italy

Trefwoorden

    Citeer dit

    Lindfors, N., Geurts, J., Drago, L., Arts, J. J., Juutilainen, V., Hyvönen, P., ... Romanò, C. L. (2017). Antibacterial bioactive glass S53P4 for chronic bone infections : a multinational study. In L. Drago (editor), A Modern Approach to Biofilm-Related Orthopaedic Implant Infections (blz. 81-92). (Advances in Experimental Medicine and Biology; Vol. 971). Dordrecht: Springer. DOI: 10.1007/5584_2016_156
    Lindfors, N. ; Geurts, J. ; Drago, L. ; Arts, J.J. ; Juutilainen, V. ; Hyvönen, P. ; Suda, A.J. ; Domenico, A. ; Artiaco, S. ; Alizadeh, C. ; Brychcy, A. ; Bialecki, J. ; Romanò, C.L./ Antibacterial bioactive glass S53P4 for chronic bone infections : a multinational study. A Modern Approach to Biofilm-Related Orthopaedic Implant Infections. redacteur / L. Drago. Dordrecht : Springer, 2017. blz. 81-92 (Advances in Experimental Medicine and Biology).
    @inbook{6651a93a2a2c4404aa9a53ef31e4fa85,
    title = "Antibacterial bioactive glass S53P4 for chronic bone infections : a multinational study",
    abstract = "Osteomyelitis is an infectious process in bone that occasionally leads to bone destruction. Traditionally the surgical treatment procedure is performed in combination with systemic and local antibiotics as a two-stage procedure that uses autograft or allograft bone for filling of the cavitary defect. Bioactive glass (BAG-S53P4) is a bone substitute with proven antibacterial and bone bonding properties. One hundred and sixteen patients who had verified chronic osteomyelitis was treated using BAG-S53P4 as part of the treatment. Most of the patients had previously undergone numerous procedures sometimes for decades. A register of patient data obtained from 11 centers from Finland Italy the Netherlands Germany Azerbaijan and Poland was set-up and continuously maintained at Helsinki University Central Hospital. The location of the osteomyelitis was mainly in the tibia followed by the femur and then the calcaneus. The median age of the patients was 48 years (15–87). The patients were either treated according to a one-stage procedure without local antibiotics (85 {\%}) or by a two-stage procedure using antibiotic beads in the first procedure (15 {\%}). The minimum follow-up was 1 year (12–95 months median 31). The cure rate was 104/116 the total success rate 90 {\%} and most of the patients showed a rapid recovery. The study shows that (BAG-S53P4) can be used in a one-stage procedure in treatment of osteomyelitis with excellent results.",
    keywords = "Antibacterial, Bioactive glass, Bone substitute, Osteomyelitis, S53P4",
    author = "N. Lindfors and J. Geurts and L. Drago and J.J. Arts and V. Juutilainen and P. Hyv{\"o}nen and A.J. Suda and A. Domenico and S. Artiaco and C. Alizadeh and A. Brychcy and J. Bialecki and C.L. Roman{\`o}",
    year = "2017",
    doi = "10.1007/5584_2016_156",
    language = "English",
    isbn = "978-3-319-52273-9",
    series = "Advances in Experimental Medicine and Biology",
    publisher = "Springer",
    pages = "81--92",
    editor = "L. Drago",
    booktitle = "A Modern Approach to Biofilm-Related Orthopaedic Implant Infections",
    address = "Germany",

    }

    Lindfors, N, Geurts, J, Drago, L, Arts, JJ, Juutilainen, V, Hyvönen, P, Suda, AJ, Domenico, A, Artiaco, S, Alizadeh, C, Brychcy, A, Bialecki, J & Romanò, CL 2017, Antibacterial bioactive glass S53P4 for chronic bone infections : a multinational study. in L Drago (redactie), A Modern Approach to Biofilm-Related Orthopaedic Implant Infections. Advances in Experimental Medicine and Biology, vol. 971, Springer, Dordrecht, blz. 81-92. DOI: 10.1007/5584_2016_156

    Antibacterial bioactive glass S53P4 for chronic bone infections : a multinational study. / Lindfors, N.; Geurts, J.; Drago, L.; Arts, J.J.; Juutilainen, V.; Hyvönen, P.; Suda, A.J.; Domenico, A.; Artiaco, S.; Alizadeh, C.; Brychcy, A.; Bialecki, J.; Romanò, C.L.

    A Modern Approach to Biofilm-Related Orthopaedic Implant Infections. redactie / L. Drago. Dordrecht : Springer, 2017. blz. 81-92 (Advances in Experimental Medicine and Biology; Vol. 971).

    Onderzoeksoutput: Hoofdstuk in Boek/Rapport/CongresprocedureHoofdstukAcademicpeer review

    TY - CHAP

    T1 - Antibacterial bioactive glass S53P4 for chronic bone infections : a multinational study

    AU - Lindfors,N.

    AU - Geurts,J.

    AU - Drago,L.

    AU - Arts,J.J.

    AU - Juutilainen,V.

    AU - Hyvönen,P.

    AU - Suda,A.J.

    AU - Domenico,A.

    AU - Artiaco,S.

    AU - Alizadeh,C.

    AU - Brychcy,A.

    AU - Bialecki,J.

    AU - Romanò,C.L.

    PY - 2017

    Y1 - 2017

    N2 - Osteomyelitis is an infectious process in bone that occasionally leads to bone destruction. Traditionally the surgical treatment procedure is performed in combination with systemic and local antibiotics as a two-stage procedure that uses autograft or allograft bone for filling of the cavitary defect. Bioactive glass (BAG-S53P4) is a bone substitute with proven antibacterial and bone bonding properties. One hundred and sixteen patients who had verified chronic osteomyelitis was treated using BAG-S53P4 as part of the treatment. Most of the patients had previously undergone numerous procedures sometimes for decades. A register of patient data obtained from 11 centers from Finland Italy the Netherlands Germany Azerbaijan and Poland was set-up and continuously maintained at Helsinki University Central Hospital. The location of the osteomyelitis was mainly in the tibia followed by the femur and then the calcaneus. The median age of the patients was 48 years (15–87). The patients were either treated according to a one-stage procedure without local antibiotics (85 %) or by a two-stage procedure using antibiotic beads in the first procedure (15 %). The minimum follow-up was 1 year (12–95 months median 31). The cure rate was 104/116 the total success rate 90 % and most of the patients showed a rapid recovery. The study shows that (BAG-S53P4) can be used in a one-stage procedure in treatment of osteomyelitis with excellent results.

    AB - Osteomyelitis is an infectious process in bone that occasionally leads to bone destruction. Traditionally the surgical treatment procedure is performed in combination with systemic and local antibiotics as a two-stage procedure that uses autograft or allograft bone for filling of the cavitary defect. Bioactive glass (BAG-S53P4) is a bone substitute with proven antibacterial and bone bonding properties. One hundred and sixteen patients who had verified chronic osteomyelitis was treated using BAG-S53P4 as part of the treatment. Most of the patients had previously undergone numerous procedures sometimes for decades. A register of patient data obtained from 11 centers from Finland Italy the Netherlands Germany Azerbaijan and Poland was set-up and continuously maintained at Helsinki University Central Hospital. The location of the osteomyelitis was mainly in the tibia followed by the femur and then the calcaneus. The median age of the patients was 48 years (15–87). The patients were either treated according to a one-stage procedure without local antibiotics (85 %) or by a two-stage procedure using antibiotic beads in the first procedure (15 %). The minimum follow-up was 1 year (12–95 months median 31). The cure rate was 104/116 the total success rate 90 % and most of the patients showed a rapid recovery. The study shows that (BAG-S53P4) can be used in a one-stage procedure in treatment of osteomyelitis with excellent results.

    KW - Antibacterial

    KW - Bioactive glass

    KW - Bone substitute

    KW - Osteomyelitis

    KW - S53P4

    UR - http://www.scopus.com/inward/record.url?scp=85019358539&partnerID=8YFLogxK

    U2 - 10.1007/5584_2016_156

    DO - 10.1007/5584_2016_156

    M3 - Chapter

    SN - 978-3-319-52273-9

    T3 - Advances in Experimental Medicine and Biology

    SP - 81

    EP - 92

    BT - A Modern Approach to Biofilm-Related Orthopaedic Implant Infections

    PB - Springer

    CY - Dordrecht

    ER -

    Lindfors N, Geurts J, Drago L, Arts JJ, Juutilainen V, Hyvönen P et al. Antibacterial bioactive glass S53P4 for chronic bone infections : a multinational study. In Drago L, redacteur, A Modern Approach to Biofilm-Related Orthopaedic Implant Infections. Dordrecht: Springer. 2017. blz. 81-92. (Advances in Experimental Medicine and Biology). Beschikbaar vanaf, DOI: 10.1007/5584_2016_156